BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 22
• 23
• 24
• 25
• 28

• Biotech Beach

  La Jolla Institute for Allergy and Immunology-Led Team Illuminates Molecular Pathway Key to Insulin Resistance in Type 2 Diabetes

  February 24, 2011

   · 

  4 min read
• Business

  IRIS International, Inc.'s Sample Processing Division Extends Exclusive Supply Agreement With IDEXX Laboratories (Israel) for an Additional Five Years

  February 24, 2011

   · 

  1 min read
• Drug Development

  Pfizer Inc.'s Crizotinib Wipes Out Rare Lymphoma in Two Test Cases

  February 24, 2011

   · 

  1 min read
• Deals

  iBio, Inc. Announces Acquisition of Fabry Disease Orphan Drug Designation and Development Program

  February 24, 2011

   · 

  1 min read
• Pharm Country

  Watson Pharmaceuticals, Inc. to Present at the 2011 Citi Global Healthcare Conference

  February 24, 2011

   · 

  1 min read
• Business

  Codexis, Inc. Names David Anton CTO & SVP, Process Development & Manufacturing

  February 24, 2011

   · 

  2 min read
• Business

  West Pharmaceutical Services Appoints Two Directors and Announces Second Quarter 2011 Dividend

  February 24, 2011

   · 

  2 min read
• PROLOR Biotech to Present at 2011 Citi Global Healthcare Conference

  February 24, 2011

   · 

  1 min read
• Business

  Symmetry Medical Inc. Reports Fourth Quarter and Full Year 2010 Financial Results

  February 24, 2011

   · 

  8 min read
• Drug Development

  Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer

  February 24, 2011

   · 

  9 min read